2026 FLASCO Spring Session Congress featuring the Business of Oncology Summit
Business of Oncology, Friday, April 10th 8:30am-3:30pm
Spring Congress, Friday, April 10th 3:30-5:30pm & Saturday, April 11th 7:30am-1:30pm
The FLASCO 2026 Spring Congress featuring the Business of Oncology Summit brings together oncology professionals for two days of strategic and clinical insight addressing the evolving realities of cancer care.
On Friday, April 10, the Business of Oncology Summit convenes thought leaders from across the country to examine the financial, operational, and regulatory forces shaping oncology delivery. Through expert panels and strategic discussion, participants will explore reimbursement pressures, CMS drug price negotiations, Medicaid variability, workforce trends, and the expanding delivery of complex therapies across sites of care.
On Saturday, April 11, Spring Congress delivers a focused clinical education program offering continuing education credit for the healthcare team. Sessions will provide evidence-based guidance on recognizing and managing toxicities associated with antibody–drug conjugates and bispecific antibodies, as well as structured debates examining the evolving role of minimal residual disease (MRD) in treatment decision-making across hematologic and solid malignancies.
Together, these programs offer a comprehensive perspective on both the clinical and business dimensions of oncology in 2026.
Please note that exhibit opportunities are available exclusively during the Spring Congress and are not offered during the Business of Oncology Summit.
Event Details
- Dates: April 10–11, 2026
- Venue: JW Marriott Orlando Bonnet Creek Resort & Spa, Orlando, FL
To register as an exhibitor for the Spring Congress or to request additional information, please contact the FLASCO office at info@flasco.org.